Compounds > 1-methyltryptophan
Page last updated: 2024-08-26

1-methyltryptophan and Colonic Neoplasms

1-methyltryptophan has been researched along with Colonic Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Dang, C; Guo, J; Jia, H; Li, J; Li, M; Li, R; Li, X; Li, Y; Liu, Z; Wang, S; Zhang, Y; Zhao, T; Zhu, G1
Ando, T; Arioka, Y; Ito, H; Saito, K; Seishima, M1
Chen, YL; Huang, TT; Lai, MD; Lin, CC; Lin, CM; Weng, TY; Wu, CL; Yang, HJ; Yen, MC1
Hara, T; Hoshi, M; Ito, H; Moriwaki, H; Nagano, J; Ninomiya, S; Ogawa, K; Saito, K; Sakai, H; Seishima, M; Shimizu, M; Tanaka, T; Tsurumi, H1
Ding, Y; Du, Q; Hu, R; Liu, X; Zhang, X; Zhou, W1

Other Studies

5 other study(ies) available for 1-methyltryptophan and Colonic Neoplasms

ArticleYear
D-MT prompts the anti-tumor effect of oxaliplatin by inhibiting IDO expression in a mouse model of colon cancer.
    International immunopharmacology, 2021, Volume: 101, Issue:Pt A

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Colonic Neoplasms; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Fluorescent Antibody Technique; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oxaliplatin; Tryptophan

2021
Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model.
    Immunology, 2015, Volume: 144, Issue:4

    Topics: Aminoquinolines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Imiquimod; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lymph Nodes; Lymphocytes, Tumor-Infiltrating; Membrane Glycoproteins; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction; Th1 Cells; Thymoma; Thyroid Neoplasms; Time Factors; Toll-Like Receptor 7; Tryptophan; Tumor Burden

2015
A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity.
    Experimental biology and medicine (Maywood, N.J.), 2010, Volume: 235, Issue:7

    Topics: Acrylamides; Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Synergism; Drug Therapy, Combination; Female; Indoleamine-Pyrrole 2,3,-Dioxygenase; Liver Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred ICR; Mice, Inbred NOD; Neoplasms, Experimental; Nicotinamide Phosphoribosyltransferase; Piperidines; Tryptophan; Urinary Bladder Neoplasms

2010
Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase.
    Cancer science, 2012, Volume: 103, Issue:5

    Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogens; Colonic Neoplasms; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Precancerous Conditions; Rats; Rats, Inbred F344; Tryptophan

2012
1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
    International journal of cancer, 2018, 09-15, Volume: 143, Issue:6

    Topics: Animals; Apoptosis; Azoxymethane; Carcinogens; Cdc20 Proteins; Cell Cycle; Cell Proliferation; Colitis; Colonic Neoplasms; Enzyme Inhibitors; Homeodomain Proteins; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitosis; Tryptophan; Tumor Cells, Cultured

2018